A Phase I trial of continuous hypertherm
โ
David L. Bartlett; Joseph F. Buell; Steven K. Libutti; Eddie Reed; Kang Bo Lee;
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 156 KB
๐ 2 views
## BACKGROUND. Tumor necrosis factor (TNF), hyperthermia, and cisplatin have synergistic cytotoxicity against cancer cells in vitro. This combination may be well suited to the regional treatment of peritoneal tumor spread in patients. Continuous hyperthermic peritoneal perfusion (CHPP) is a techni